CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. (Q38317100)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. |
scientific article |
Statements
CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer (English)
Hartwig Huland
Sarah Minner
Guido Sauter
Thorsten Schlomm
Martina Kluth
Lia Burkhardt
Sawinee Masser
Sarah Fuchs
Antje Krohn
Frederik Bachmann
Thomas Steuber
Markus Graefen
14 March 2013
1 reference